An unusual case of multifocal central serous chorioretinopathy with low serum cortisol managed using eplerenone

In this report, we describe a rare case of a 44-year-old Asian male with acute central serous chorioretinopathy (CSC) with bullous exudative retinal detachment. Endocrinology evaluation revealed hypothalamic–pituitary–adrenal axis suppression with low serum cortisol. Furthermore, neuroimaging revealed the presence of a pituitary microadenoma. He was treated with systemic eplerenone and hydrocortisone. After 12 weeks, bullous detachment completely resolved. Our case is a unique description of acute CSC with underlying low serum cortisol levels that responded to treatment with mineralocorticoid antagonist. This case highlights the various endocrine abnormalities other than the raised serum cortisol that can occur in patients with CSC.

[1]  J. Vander,et al.  A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR) , 2017, Retina.

[2]  S. Bakri,et al.  Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. , 2018, Survey of ophthalmology.

[3]  A. Loewenstein,et al.  Eplerenone for chronic central serous chorioretinopathy–a randomized controlled prospective study , 2017, Acta ophthalmologica.

[4]  Z. Nagy,et al.  MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES , 2017, Retina.

[5]  D. Eliott,et al.  Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy , 2017, Seminars in ophthalmology.

[6]  Jesse J. Jung,et al.  CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY , 2016, Retina.

[7]  C. Regillo,et al.  Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. , 2015, Ophthalmic surgery, lasers & imaging retina.

[8]  H. Ghanbari,et al.  Central serous chorioretinopathy following kidney transplantation. , 2014, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[9]  Min Zhao,et al.  MINERALOCORTICOID RECEPTOR ANTAGONISM IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2013, Retina.

[10]  Aman Sharma,et al.  Dark Spot in Fibrinous Central Serous Chorioretinopathy Masquerading Choroiditis , 2013, Ocular immunology and inflammation.

[11]  Min Zhao,et al.  Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. , 2012, The Journal of clinical investigation.

[12]  F. Pakdel,et al.  Hyperthyroid vs hypothyroid eye disease: the same severity and activity , 2011, Eye.

[13]  K. Kumar,et al.  Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease , 2009, Postgraduate Medical Journal.

[14]  D. Eliott,et al.  Optical coherence tomographic findings in pregnancy-associated central serous chorioretinopathy , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  J. Melby,et al.  Endocrine abnormalities in patients with central serous chorioretinopathy. , 2003, Ophthalmology.

[16]  A. Sari,et al.  Electrophysiological effects of corticosteroids on the retinal pigment epithelium. , 2001, Investigative ophthalmology & visual science.

[17]  C. Schmid,et al.  Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. , 2000, Retina.

[18]  J. Gass,et al.  Idiopathic central serous chorioretinopathy. , 1998, Indian journal of ophthalmology.

[19]  M. Kaiser-Kupfer,et al.  Central serous chorioretinopathy in endogenous hypercortisolism. , 1993, Archives of ophthalmology.

[20]  A. Lassus,et al.  Systemic side-effects of three topical steroids in diseased skin. , 1983, Current medical research and opinion.

[21]  R. Frank,et al.  Central serous retinopathy and pregnancy. , 1974, American journal of ophthalmology.

[22]  P. Kadowitz,et al.  Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. , 1974, European Journal of Pharmacology.

[23]  J D Gass,et al.  Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.